Abstract

Objective: To assess various methods of management of actinomyces-like organisms associated with intrauterine devices. Methods: A retrospective chart review of 173 patients with intrauterine device-associated actinomyces- like organisms detected on Pap smear was performed. The patients were managed by IUD removal with or without antibiotic therapy, antibiotic therapy alone, or no treatment at all. Results: The success rate as reflected in negative follow-up smear was 100% for IUD removal combined with antibiotics, 97.4% for IUD removal alone, and 36.8% for antibiotics therapy alone. Conclusions: The best way to manage intrauterine device-associated actinomyces-like organisms is removal of the device with or without antibiotics.

Highlights

  • A retrospective chart review of 173 patients with intrauterine device-associated actinomyces-like organisms detected on Pap smear was performed

  • There was a total of 173 patients with intrauterine contraceptive devices (IUDs)-associated actinomyces-like organisms (ALOs) on cervicovaginal Pap smear

  • Our retrospective analysis indicates that the best form of treatment for IUD-associated ALOs is

Read more

Summary

Methods

A retrospective chart review of 173 patients with intrauterine device-associated actinomyces-like organisms detected on Pap smear was performed. 4. Gupta and associatess-7 first described the histomorphologic identification of the carriage of actinomyces-like organisms (ALOs) and their association with IUDs on Pap smears. The management of IUD-associated ALOs identified on a cervicovaginal Pap smear, especially in an asymptomatic woman, is difficult, controversial, and without any uniform consensus. It ranges from leaving the IUD in situ to removal, with or without reinsertion of a new IUD or antibiotic treatment. Our study assesses some of the ways to manage ALOs diagnosed by cervicovaginal Pap smears in asymptomatic IUD users

MATERIALS AND METHODS
RESULTS
UD-ASSOCIATED ACTINOMYCOSIS
Israel J
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call